"There are two major reasons for you to confirm accuracy: to be sure that fraudulent claims are not being submitted and to confirm that the claims accurately reflect the work you have performed," write Ray Painter, MD, and Mark Painter.
"It is imperative that APPs are active in advocacy for issues that remove barriers and ensure direct access to patients for their services," writes Adele M. Caruso, DNP, CRNP.
"Clearly, we are overprescribing and in some cases very seriously overprescribing nationally—regardless of procedure," says study author Jennifer A. Robles, MD.
"Overall, the 2020 Medicare payment proposal attempts to modernize the program and mitigate administrative burdens. The urologic community has identified room for improvement, however, including in the area of facilitating participation in advanced payment models," writes the AACU's Ross E. Weber.
Urotronic, Inc. said it has received an investigational device exemption approval from the FDA to begin its U.S. pivotal study for the Optilume BPH Catheter System.
This article will discuss obstacles that urologists typically must address when implementing telemedicine into their practice.
Igor Sorokin, MD, presents the case of a 36-year-old female in whom two proximal stones are seen on KUB, but intraoperatively, only one stone is seen.
In this video, Sandip Vasavada, MD, of the Center for Female Urology and Reconstructive Pelvic Surgery, Cleveland Clinic, explains how the recently updated AUA/SUFU clinical guideline for overactive bladder helps urologists treat the condition.
Three novel androgen receptor inhibitors provide an embarrassment of riches when it comes to treatment options for nmCRPC patients, but there are still questions to be answered—including the extent of these drugs’ clinical benefit.
"There is tremendous diversity within urology, enabling clinicians to practice in a variety of ways and settings, and there is clearly a huge demand for female providers," says Mara R. Holton, MD.